Millennium Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $844K | Buy |
|
|||||
|
2025
Q2 | $183K | Sell |
|
|||||
|
2025
Q1 | $2.38M | Sell |
|
|||||
|
2024
Q4 | $13.9M | Buy |
|
|||||
|
2024
Q3 | $33.3M | Buy |
|
|||||
|
2024
Q2 | $18M | Buy |
|
|||||
|
2024
Q1 | $22.4M | Sell |
|
|||||
|
2023
Q4 | $20.8M | Buy |
|
|||||
|
2023
Q3 | $6.51M | Buy |
|
|||||
|
2023
Q2 | $1.6M | Buy |
|
|||||
|
2023
Q1 | $1.04M | Sell |
|
|||||
|
2022
Q4 | $8.71M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3.57M | Buy |
|
|||||
|
2021
Q4 | $3.09M | Sell |
|
|||||
|
2021
Q3 | $7.2M | Buy |
|
|||||
|
2021
Q2 | $4.96M | Sell |
|
|||||
|
2021
Q1 | $8.02M | Buy |
|
|||||
|
2020
Q4 | $6.2M | Buy |
|
|||||
|
2020
Q3 | $337 | Buy |
|